641
Views
16
CrossRef citations to date
0
Altmetric
Studies in humans

Myo-inositol supplementation to prevent gestational diabetes in overweight non-obese women: bioelectrical impedance analysis, metabolic aspects, obstetric and neonatal outcomes – a randomized and open-label, placebo-controlled clinical trial

ORCID Icon, , ORCID Icon, ORCID Icon, , ORCID Icon & ORCID Icon show all
Pages 670-679 | Received 16 Oct 2020, Accepted 13 Nov 2020, Published online: 25 Nov 2020

References

  • Bain E, Crane M, Tieu J, Han S, Crowther CA, Middleton P. 2015. Diet and exercise interventions for preventing gestational diabetes mellitus. Cochrane Database Syst Rev. (4):CD010443.
  • Brown J, Crawford TJ, Alsweiler J, Crowther CA. 2016. Dietary supplementation with myo-inositol in women during pregnancy for treating gestational diabetes. Cochrane Database Syst Rev. 9(9):CD012048.
  • Carpenter MW, Coustan DR. 1982. Criteria for screening tests for gestational diabetes. Am J Obstet Gynecol. 144(7):768–773.
  • Cho GJ, Yoon HJ, Kim EJ, Oh MJ, Seo HS, Kim HJ. 2011. Postpartum changes in body composition. Obesity (Silver Spring). 19(12):2425–2428.
  • Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. National Diabetes Data Group. Diabetes. 28(12):1039–1057.
  • Clements RS, Jr, Darnell B. 1980. Myo-inositol content of common foods: development of a high-myo-inositol diet. Am J Clin Nutr. 33(9):1954–1967.
  • Corrado F, D’Anna R, Di Vieste G, Giordano D, Pintaudi B, Santamaria A, Di Benedetto A. 2011. The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes. Diabet Med. 28(8):972–975.
  • Corrado F, Pintaudi B, Di Vieste G, Interdonato ML, Magliarditi M, Santamaria A, D’Anna R, Di Benedetto A. 2014. Italian risk factor-based screening for gestational diabetes. J Matern Fetal Neonatal Med. 27(14):1445–1448.
  • Croze ML, Soulage CO. 2013. Potential role and therapeutic interests of myo-inositol in metabolic diseases. Biochimie. 95(10):1811–1827.
  • Davey RX. 2005. Gestational diabetes mellitus: a review from 2004. Curr Diabetes Rev. 1(2):203–213.
  • D’Anna R, Scilipoti A, Giordano D, Caruso C, Cannata ML, Interdonato ML, Corrado F, Di Benedetto A. 2013. myo-Inositol supplementation and onset of gestational diabetes mellitus in pregnant women with a family history of type 2 diabetes: a prospective, randomized, placebo-controlled study. Diabetes Care. 36(4):854–857.
  • DʼAnna R, Di Benedetto A, Scilipoti A, Santamaria A, Interdonato ML, Petrella E, Neri I, Pintaudi B, Corrado F, Facchinetti F. 2015. Myo-inositol supplementation for prevention of gestational diabetes in obese pregnant women: a randomized controlled trial. Obstet Gynecol. 126(2):310–315.
  • Facchinetti F, Dante G, Petrella E, Neri I. 2014. Dietary interventions, lifestyle changes, and dietary supplements in preventing gestational diabetes mellitus: a literature review. Obstet Gynecol Surv. 69(11):669–680.
  • Fattah C, Farah N, Barry SC, O’Connor N, Stuart B, Turner MJ. 2010. Maternal weight and body composition in the first trimester of pregnancy. Acta Obstet Gynecol Scand. 89(7):952–955.
  • Genazzani AD, Lanzoni C, Ricchieri F, Jasonni VM. 2008. Myo-inositol administration positively affects hyperinsulinemia and hormonal parameters in overweight patients with polycystic ovary syndrome. Gynecol Endocrinol. 24(3):139–144.
  • Ghezzi F, Franchi M, Balestreri D, Lischetti B, Mele MC, Alberico S, Bolis P. 2001. Bioelectrical impedance analysis during pregnancy and neonatal birth weight. Eur J Obstet Gynecol Reprod Biol. 98(2):171–176.
  • Gur EB, Ince O, Turan GA, Karadeniz M, Tatar S, Celik E, Yalcin M, Guclu S. 2014. Ultrasonographic visceral fat thickness in the first trimester can predict metabolic syndrome and gestational diabetes mellitus. Endocrine. 47(2):478–484.
  • Hedderson MM, Gunderson EP, Ferrara A. 2010. Gestational weight gain and risk of gestational diabetes mellitus. Obstet Gynecol. 115(3):597–604.
  • Hedderson MM, Williams MA, Holt VL, Weiss NS, Ferrara A. 2008. Body mass index and weight gain prior to pregnancy and risk of gestational diabetes mellitus. Am J Obstet Gynecol. 198(4):409.e1–409.e7.
  • Heymsfield SB, Wang Z, Visser M, Gallagher D, Pierson RN. Jr. 1996. Techniques used in the measurement of body composition: an overview with emphasis on bioelectrical impedance analysis. Am J Clin Nutr. 64(3 Suppl):478S–484S.
  • Imam K. 2013. Chapter 4, Gestational diabetes mellitus. In: Diabetes. Advances in experimental medicine and biology. New York (NY): Springer; p. 24–34.
  • Kahn SE, Prigeon RL, Schwartz RS, Fujimoto WY, Knopp RH, Brunzell JD, Porte D, Jr. 2001. Obesity, body fat distribution, insulin sensitivity and Islet beta-cell function as explanations for metabolic diversity. J Nutr. 131(2):354S–360S.
  • Kim C. 2010. Gestational diabetes: risks, management, and treatment options. Int J Womens Health. 2:339–351.
  • Kirwan JP, Hauguel-De Mouzon S, Lepercq J, Challier JC, Huston-Presley L, Friedman JE, Kalhan SC, Catalano PM. 2002. TNF-alpha is a predictor of insulin resistance in human pregnancy. Diabetes. 51(7):2207–2213.
  • Kotsis V, Stabouli S, Papakatsika S, Rizos Z, Parati G. 2010. Mechanisms of obesity-induced hypertension. Hypertens Res. 33(5):386–393.
  • Larciprete G, Valensise H, Vasapollo B, Altomare F, Sorge R, Casalino B, De Lorenzo A, Arduini D. 2003. Body composition during normal pregnancy: reference ranges. Acta Diabetol. 40 Suppl 1:S225–S232.
  • Lukaski HC. 1996. Biological indexes considered in the derivation of the bioelectrical impedance analysis. Am J Clin Nutr. 64(3 Suppl):397S–404S.
  • Lukaski HC, Bolonchuk WW. 1988. Estimation of body fluid volumes using tetrapolar bioelectrical impedance measurements. Aviat Space Environ Med. 59(12):1163–1169.
  • Metzger BE, Buchanan TA, Coustan DR, de Leiva A, Dunger DB, Hadden DR, Hod M, Kitzmiller JL, Kjos SL, Oats JN, et al. 2007. Summary and recommendations of the Fifth International Workshop-Conference on Gestational Diabetes Mellitus. Diabetes Care. 30 Suppl 2:S251–S260.
  • Metzger BE, Gabbe SG, Persson B, Buchanan TA, Catalano PA, Damm P, Dyer AR, Leiva A, Hod M, Kitzmiler JL, et al. 2010. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care. 33(3):676–682.
  • Metzger BE, Lowe LP, Dyer AR, Trimble ER, Chaovarindr U, Coustan DR, Hadden DR, McCance DR, Hod M, McIntyre HD, et al. 2008. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med. 358(19):1991–2002.
  • Mirghani Dirar A, Doupis J. 2017. Gestational diabetes from A to Z. World J Diabetes. 8(12):489–511.
  • O’Sullivan JB, Mahan CM. 1964. Criteria for the oral glucose tolerance test in pregnancy. Diabetes. 13:278–285.
  • O’Sullivan JB, Mahan CM, Charles D, Dandrow RV. 1973. Screening criteria for high-risk gestational diabetic patients. Am J Obstet Gynecol. 116(7):895–900.
  • Pintaudi B, Di Vieste G, Corrado F, Lucisano G, Pellegrini F, Giunta L, Nicolucci A, D’Anna R, Di Benedetto A. 2014. Improvement of selective screening strategy for gestational diabetes through a more accurate definition of high-risk groups. Eur J Endocrinol. 170(1):87–93.
  • Santamaria A, Alibrandi A, Di Benedetto A, Pintaudi B, Corrado F, Facchinetti F, D’Anna R. 2018. Clinical and metabolic outcomes in pregnant women at risk for gestational diabetes mellitus supplemented with myo-inositol: a secondary analysis from 3 RCTs. Am J Obstet Gynecol. 219(3):300.e1–300.e6.
  • Santamaria A, Di Benedetto A, Petrella E, Pintaudi B, Corrado F, D’Anna R, Neri I, Facchinetti F. 2016. Myo-inositol may prevent gestational diabetes onset in overweight women: a randomized, controlled trial. J Matern Fetal Neonatal Med. 29(19):3234–3237.
  • Segal KR, Kral JG, Wang J, Pierson RN, Van Itallie TB. 1987. Estimation of body water distribution by bioelectrical impedance. Fed Proc. 46:1334.
  • Shah BR, Retnakaran R, Booth GL. 2008. Increased risk of cardiovascular disease in young women following gestational diabetes mellitus. Diabetes Care. 31(8):1668–1669.
  • Sistema Nazionale per le Linee Guida – Istituto Superiore di Sanità. 2011. Linee Guida su Gravidanza Fisiologica. Aggiornamento 2011. Available from: http://www.salute.gov.it/imgs/C_17_pubblicazioni_1436_allegato.pdf.
  • Sommer C, Mørkrid K, Jenum AK, Sletner L, Mosdøl A, Birkeland KI. 2014. Weight gain, total fat gain and regional fat gain during pregnancy and the association with gestational diabetes: a population-based cohort study. Int J Obes (Lond). 38(1):76–81.
  • Staelens AS, Vonck S, Molenberghs G, Malbrain ML, Gyselaers W. 2016. Maternal body fluid composition in uncomplicated pregnancies and preeclampsia: a bioelectrical impedance analysis. Eur J Obstet Gynecol Reprod Biol. 204:69–73.
  • Tarazi RC. 1976. Hemodynamic role of extracellular fluid in hypertension. Circ Res. 38(6 Suppl 2):73–83.
  • Tazegül Pekin A, Yılmaz SA, Kerimoğlu ÖS, Çelik G, Doğan NU, Beyhekim H, Çelik Ç. 2015. Assessment of body composition with bioelectrical impedance analysis in pregnant women with hyperemesis gravidarum before and after treatment. J Obstet Gynaecol. 35(6):561–564.
  • Valensise H, Andreoli A, Lello S, Magnani F, Romanini C, De Lorenzo A. 2000. Multifrequency bioelectrical impedance analysis in women with a normal and hypertensive pregnancy. Am J Clin Nutr. 72(3):780–783.
  • Wang J, Pierson RN. Jr. 1976. Disparate hydration of adipose and lean tissue require a new model for body water distribution in man. J Nutr. 106(12):1687–1693.
  • Yilmaz O, Kucuk M, Ilgin A, Dagdelen M. 2010. Assessment of insulin sensitivity/resistance and their relations with leptin concentrations and anthropometric measures in a pregnant population with and without gestational diabetes mellitus. J Diabetes Complications. 24(2):109–114.
  • Zhang Y, Wang ZL, Liu B, Cai J. 2014. Pregnancy outcome of overweight and obese Chinese women with gestational diabetes. J Obstet Gynaecol. 34(8):662–665.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.